Cost Profile and Budget Implications of Rechargeable Versus Non-rechargeable Sacral Neuromodulation Devices for Neurogenic Lower Urinary Tract Dysfunction

NCT07173517 | Not Yet Recruiting DMC

• 1 other identifier: KYLL-202505-101
• Study Type: observational
• Target: 268
• Locations: 1 country
• Sites: 1

Brief Summary

Traditional sacral neuromodulation devices are not rechargeable. In recent years, new rechargeable sacral neuromodulation devices have been developed and put into the market. The aim of this study was to evaluate the cost savings of a rechargeable sacral neuromodulation device versus a non-rechargeable sacral neuromodulation device for the treatment of neurogenic lower urinary tract dysfunction.

Conditions

Rechargeable Sacral Neuromodulation Device; Neurogenic Lower Urinary Tract Dysfunction

Keywords

neurogenic lower urinary tract dysfunction; cost-savings; sacral neuromodulation; rechargeable

Outcome Measures

Primary Outcomes (1)

• Costs associated with sacral neuromodulation therapy

  Costs associated with sacral neuromodulation therapy

  From August 2020 to January 2025

Study Arms (2)

rechargeable group

non-rechargeable group

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

They were treated with rechargeable or non-rechargeable sacral neuromodulation devices

You may qualify if:

• male and female patients with neurogenic lower urinary tract dysfunction who had failed conventional treatment
• obstructive urinary retention and contraindications to SNM

Sponsors & Collaborators

• Qilu Hospital of Shandong University: lead
• Aerospace Center Hospital: collaborator
• Shandong Provincial Hospital: collaborator
• Second Affiliated Hospital of Xi'an Jiaotong University: collaborator
• Beijing Hospital: collaborator
• Xi'an Honghui Hospital: collaborator
• The First Affiliated Hospital of Zhengzhou University: collaborator
• Second Hospital of Jilin University: collaborator
• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: collaborator
• Tongji Hospital: collaborator

Study Sites (1)

Qilu Hospital

Jinan, Shandong, China

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

No biological samples were involved and only patient information was collected

Central Study Contacts

Yan Li, Ph.D degree

CONTACT

+86 18560089113; yanli@sdu.edu.cn

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 7, 2025
• First Posted: September 15, 2025
• Study Start: October 1, 2025
• Primary Completion: April 30, 2026
• Study Completion: April 30, 2026
• Last Updated: September 15, 2025

Record last verified: 2025-07

Locations

CN (1)